Transl Clin Pharmacol.  2023 Jun;31(2):69-84. 10.12793/tcp.2023.31.e9.

A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians

• Choi K

• KMID: 2552408
• DOI: http://doi.org/10.12793/tcp.2023.31.e9

Abstract

This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the Bayesian methods with minimal requirement of mathematical theory. They do not require any closed form of the posterior density nor linear approximation of complex nonlinear models in high dimension even with non-conjugate priors. The HMC even weakens the dependency of the chain and improves computational efficiency. Pharmacometrics is one of great beneficiaries since they use complex multivariate multilevel nonlinear mixed effects models based on the restricted maximum likelihood estimation. Comprehension of the Bayesian approach will help pharmacometricians to access the data analysis more conveniently.

Keyword

Likelihood Estimates; Bayesian Inference; Monte Carlo Markov Chain; Hamiltonian Monte Carlo